MedTrace Logo

Pilot Study "AHSP as a Biomarker of Sickle Cell Disease in a Population of Adults and Children"

NCT06735625 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-04-02

No results posted yet for this study

Summary

Evaluation of AHSP concentration in total blood as a biomarker in adult and pediatric sickle cell patients

Conditions

  • in Relation to Sickle Cell Disease

Interventions

BIOLOGICAL

Measurement of AHSP concentration

Pseudonymization and identification of research samples EDTA tube of 4 mL for patients over 15 and a half years old, and 2 EDTA tubes of 2 mL for children aged 3 to 15 and a half years, totaling 4 mL) by Team 4 according to the procedure in force at the URC. The 4 mL research sample will then be divided into 1 mL fractions by a technician in the laboratory and stored at -80°C in the medical biology laboratory.

Sponsors & Collaborators

  • Inserm U955

    collaborator OTHER

  • Centre Hospitalier de Saint-Denis

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
3 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-06
Primary Completion
2026-03-20
Completion
2027-01-20

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06735625 on ClinicalTrials.gov